Mariana Lazo

ORCID: 0000-0002-3178-6734
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Alcohol Consumption and Health Effects
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Health disparities and outcomes
  • Cardiovascular Disease and Adiposity
  • Global Public Health Policies and Epidemiology
  • Substance Abuse Treatment and Outcomes
  • Folate and B Vitamins Research
  • Nutritional Studies and Diet
  • Hepatitis C virus research
  • Lipoproteins and Cardiovascular Health
  • Cardiac Imaging and Diagnostics
  • Advanced Glycation End Products research
  • Diet and metabolism studies
  • Heart Failure Treatment and Management
  • Obesity, Physical Activity, Diet
  • Food Security and Health in Diverse Populations
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Hepatitis B Virus Studies

Drexel University
2020-2025

Johns Hopkins University
2015-2024

Johns Hopkins Medicine
2015-2024

Philadelphia Department of Public Health
2021-2023

Universidade Federal do Rio Grande
2023

Prefeitura Municipal de Belo Horizonte
2023

Welch Foundation
2013-2021

Universidad Mariana
2012-2019

Johns Hopkins Hospital
2015-2018

Bloomberg (United States)
2012-2018

Depressive symptoms are associated with development of type 2 diabetes, but it is unclear whether diabetes a risk factor for elevated depressive symptoms.To examine the bidirectional association between and diabetes.Multi-Ethnic Study Atherosclerosis, longitudinal, ethnically diverse cohort study US men women aged 45 to 84 years enrolled in 2000-2002 followed up until 2004-2005.Elevated defined by Center Epidemiologic Studies Depression Scale (CES-D) score 16 or higher, use antidepressant...

10.1001/jama.299.23.2751 article EN JAMA 2008-06-17

Previous estimates of the prevalence nonalcoholic fatty liver disease (NAFLD) in US population relied on measures enzymes, potentially underestimating burden this disease. We used ultrasonography data from 12,454 adults who participated Third National Health and Nutrition Examination Survey, conducted United States 1988 to 1994. defined NAFLD as presence hepatic steatosis absence elevated alcohol consumption. In population, rates were 21.4% 19.0%, respectively, corresponding 32.5 (95%...

10.1093/aje/kws448 article EN American Journal of Epidemiology 2013-05-23

The prognoses with respect to mortality and hepatic nonhepatic outcomes across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well defined.

10.1056/nejmoa2029349 article EN New England Journal of Medicine 2021-10-20

The benzopyranopyrrole S33084 displayed pronounced affinity (p<i>K</i><sub>i</sub> = 9.6) for cloned human hD<sub>3</sub>-receptors, and &gt;100-fold lower hD<sub>2</sub> all other receptors (&gt;30) examined. concentration dependently, potently, competitively (pA<sub>2</sub> 9.7) antagonized dopamine (DA)-induced [<sup>35</sup>S]guanosine-5′-<i>O</i>-(3-thio)triphosphate (GTPγS) binding at hD<sub>3</sub>-receptors. It also dependently abolished stimulation by DA of...

10.1136/bmj.d6891 article EN cc-by-nc BMJ 2011-11-18

OBJECTIVE Weight loss through lifestyle changes is recommended for nonalcoholic fatty liver disease (NAFLD). However, its efficacy in patients with type 2 diabetes unproven. RESEARCH DESIGN AND METHODS Look AHEAD (Action Health Diabetes) a 16-center clinical trial 5,145 overweight or obese adults diabetes, who were randomly assigned to an intensive intervention (ILI) induce minimum weight of 7% control group received support and education (DSE). In the Fatty Liver Ancillary Study, 96...

10.2337/dc10-0856 article EN cc-by-nc-nd Diabetes Care 2010-07-27
Mohammad Shadab Siddiqui Goro Yamada Raj Vuppalanchi Mark L. Van Natta Rohit Loomba and 95 more Cynthia D. Guy Danielle Brandman James Tonascia Naga Chalasani Brent A. Neuschwander‐Tetri Arun J. Sanyal Daniela Allende Srinivasan Dasarathy Arthur J. McCullough Revathi Penumatsa Jaividhya Dasarathy Joel E. Lavine Manal F. Abdelmalek Mustafa R. Bashir Stephanie Buie Anna Mae Diehl Cynthia D. Guy Christopher Kigongo Mariko Kopping David Malik Dawn Piercy Naga Chalasani Oscar W. Cummings Samer Gawrieh Linda Ragozzino Kumar Sandrasegaran Raj Vuppalanchi Elizabeth M. Brunt Theresa Cattoor Danielle Carpenter Janet Freebersyser Debra King Jinping Lai Brent A. Neuschwander‐Tetri Joan Siegner Susan L. Stewart Susan Torretta Kristina Wriston Maria Cardona Gonzalez Jodie Davila Manan Jhaveri Kris V. Kowdley Nizar A. Mukhtar Erik Ness Michelle Poitevin Brook A. Quist Sherilynn Soo Brandon Ang Cynthia Behling Archana Bhatt Rohit Loomba Michael S. Middleton Claude B. Sirlin Maheen F. Akhter Nathan M. Bass Danielle Brandman Ryan M. Gill Bilal Hameed Jacqueline Maher Norah A. Terrault Ashley Ungermann Matthew M. Yeh Sherry Boyett Melissa J. Contos S. Kirwin Velimir A. Luketic Prem Puri Arun J. Sanyal Jolene Schlosser Mohammad Shadab Siddiqui Leslie Yost-Schomer Elizabeth M. Brunt Kathryn J. Fowler David E. Kleiner Edward Doo Sherry Hall Jay H. Hoofnagle Jessica J. Lee Patricia R. Robuck Averell H. Sherker Rebecca Torrance Patricia Belt Jeanne M. Clark J.A. Dodge Michele Donithan Erin Hallinan Milana Isaacson Mariana Lazo Jill Meinert Laura Miriel Jacqueline Smith Michael L. Smith Jürgen Floege James Tonascia Mark L. Van Natta

10.1016/j.cgh.2018.12.031 article EN publisher-specific-oa Clinical Gastroenterology and Hepatology 2019-01-05

Obesity is a risk factor for various subtypes of cardiovascular disease (CVD), including coronary heart (CHD), failure (HF), and stroke. Nevertheless, there are limited comparisons the associations obesity with each these CVD subtypes, particularly regarding extent to which they unexplained by traditional mediators. We followed 13 730 participants in Atherosclerosis Risk Communities (ARIC) study who had body mass index ≥18.5 no at baseline (visit 1, 1987-1989). compared association higher...

10.1161/jaha.116.003921 article EN cc-by-nc-nd Journal of the American Heart Association 2016-07-29

Background— Persons with prediabetes and diabetes mellitus are at high risk for cardiovascular events. However, the relationships of to development subclinical myocardial damage unclear. Methods Results— We measured cardiac troponin T a highly sensitive assay (hs-cTnT) 2 time points, 6 years apart, among 9051 participants community-based Atherosclerosis Risk in Communities Study no mellitus, or prediabetes, without disease including silent infarction by ECG. First, we examined incidence...

10.1161/circulationaha.114.010815 article EN Circulation 2014-08-23

The risk of nonalcoholic fatty liver disease (NAFLD) among obese individuals without obesity-related metabolic abnormalities, a condition referred to as metabolically healthy (MHO), is largely unexplored. Therefore, we examined the association between body mass index (BMI) categories and development NAFLD in large cohort men women.A study was conducted 77,425 women free abnormalities at baseline, who were followed-up annually or biennially for an average 4.5 years. Being defined not having...

10.1038/ajg.2016.178 article EN The American Journal of Gastroenterology 2016-05-17

Fructose consumption predicts increased hepatic fibrosis in those with nonalcoholic fatty liver disease (NAFLD). Because of its ability to lower adenosine triphosphate (ATP) levels, habitual fructose could result more ATP depletion and impaired recovery. The degree after an intravenous (IV) challenge test low- versus high-fructose consumers was assessed. We evaluated diabetic adults enrolled the Action for Health Diabetes Fatty Liver Ancillary Study (n = 244) whom dietary estimated by a...

10.1002/hep.25741 article EN Hepatology 2012-04-01

We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless presence cardiovascular (CVD) or its risk factors.This was cross-sectional study 4,472 adults aged 20-59 years who participated Third National Health and Nutritional Examination Survey. The participants underwent assessment enzyme activity hepatic steatosis by ultrasound, evaluation using following...

10.1212/wnl.0000000000002498 article EN Neurology 2016-02-25

Cuba's economic crisis of 1989–2000 resulted in reduced energy intake, increased physical activity, and sustained population-wide weight loss. The authors evaluated the possible association these factors with mortality trends. Data on per capita daily loss, smoking were systematically retrieved from national local surveys. National vital statistics 1980–2005 used to assess trends diabetes, coronary heart disease, stroke, cancer, all causes. intake 2,899 calories 1,863 calories. During...

10.1093/aje/kwm226 article EN American Journal of Epidemiology 2007-09-06

Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, was associated with subclinical atherosclerosis in many cross-sectional studies, but prospective association between NAFLD and progression has not been evaluated. This study conducted to evaluate coronary atherosclerosis.This retrospective cohort included 4731 adult men women no history cardiovascular (CVD), or cancer at baseline who participated repeated regular health screening examination 2004...

10.1136/gutjnl-2016-311854 article EN Gut 2016-09-06

To characterize the prevalence of nonalcoholic fatty liver disease (NAFLD) by race in a nationally representative sample U.S. population and to investigate potential explanatory factors for racial disparities.Cross-sectional study 4,037 non-Hispanic white, 2,746 black, 2,892 Mexican-American adults Third National Health Nutrition Examination Survey. NAFLD was defined using ultrasound with elevated aminotransferases.Age-adjusted highest Mexican-Americans (21.2%), followed whites (12.5%),...

10.1002/oby.20426 article EN Obesity 2013-03-20

The benefits of physical activity are well documented, but scalable programs to promote needed. Interventions that assign tailored and dynamically adjusting goals could effect significant increases in have not yet been implemented at scale.Our aim was examine the effectiveness an open access, Internet-based walking program assigns daily step each participant.A two-arm, pragmatic randomized controlled trial compared intervention no treatment. Participants were recruited from a workplace...

10.2196/jmir.5295 article EN cc-by Journal of Medical Internet Research 2016-02-09
Coming Soon ...